Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Target price


12.08.22 / Tradegate WKN: A1XDTL / Symbol: ITCI / Name: ITI / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Intra-Cellular Therapies Inc. Stock

We can see a decrease in the price for Intra-Cellular Therapies Inc.. Compared to yesterday it has lost -€1.220 (-2.210%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Intra-Cellular Therapies Inc. stock is not clear.
As a result the target price of €65.00 shows a positive potential of 24.473% compared to the current price of €52.22 for Intra-Cellular Therapies Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Intra-Cellular Therapies Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Intra-Cellular Therapies Inc. in the next few years

G***** c******* t* c**********
C******** o* t** e**********
W********* I********* f** t** n*** y****
M***** P*******
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Intra-Cellular Therapies Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Intra-Cellular Therapies Inc. -2.210% -8.993% -7.673% 110.395% 14.292% 539.559% 378.731%
Kala Pharmaceuticals 3.000% -1.322% -1.941% -87.631% -67.835% - -
Epizyme Inc. -0.690% -4.667% -1.379% -69.562% -36.246% -88.061% -
Pieris Pharmaceuticals Inc -1.160% -8.793% -19.370% -53.366% -48.240% -67.567% -


Buy Intra-Cellular Therapies Inc.
Show more